BrainLife
Library
CNS Tumors
Treatment


Home > Library > CNS Tumors > Treatment


Sections



OVERVIEW


ANTICONVULSANTS


BLOOD-BRAIN BARRIER MANAGEMENT


BOOKS


DRUG DELIVERY


DRUG REPURPOSING


IMMUNOTHERAPY


RADIOSURGERY


RADIOTHERAPY


STEM CELL THERAPY


SURGERY


TEMOZOLOMIDE


TARGETED THERAPY


THERMAL THERAPY



Overview




BLOOD-BRAIN BARRIER



Semyachkina-Glushkovskaya O, Kurths J, Borisova E, Sokolovski S, Mantareva V, Angelov I, Shirokov A, Navolokin N, Shushunova N, Khorovodov A, Ulanova M, Sagatova M, Agranivich I, Sindeeva O, Gekalyuk A, Bodrova A, Rafailov E.
Photodynamic opening of blood-brain barrier.
Biomed Opt Express. 2017 Oct 17;8(11):5040-5048. doi: 10.1364/BOE.8.005040.
Source _ Similar articles



DRUG DELIVERY



Shah V, Kochar P.
Brain Cancer: Implication to disease, therapeutic strategies and tumor targeted drug delivery approaches.
Recent Pat Anticancer Drug Discov. 2017 Nov 29. doi: 10.2174/1574892812666171129142023. [Epub ahead of print]
Source _ Similar articles



NANOMEDICINE



Reynolds JL, Mahato RI.
Nanomedicines for the Treatment of CNS Diseases.
J Neuroimmune Pharmacol. 2017 Mar;12(1):1-5. doi: 10.1007/s11481-017-9725-x. Epub 2017 Feb 1.
Source _ Similar articles



R.A.N.O. RESPONSE CRITERIA



Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ.
Response Assessment in Neuro-Oncology Clinical Trials.
J Clin Oncol. 2017 Jun 22:JCO2017727511. doi: 10.1200/JCO.2017.72.7511. [Epub ahead of print]
Source _ Similar articles



CHILDHOOD BRAIN AND SPINAL CORD TUMORS


.

Rutka JT.
Malignant Brain Tumours in Children : Present and Future Perspectives.
J Korean Neurosurg Soc. 2018 May;61(3):402-406. doi: 10.3340/jkns.2018.0044. Epub 2018 May 1.
Source _ Similar articles



RADIOTHERAPY



Baliga S, Yock TI.
Proton beam therapy in pediatric oncology.
Curr Opin Pediatr. 2019 Feb;31(1):28-34. doi: 10.1097/MOP.0000000000000724.
Source _ Similar articles




Combs SE.
Does Proton Therapy Have a Future in CNS Tumors?
Curr Treat Options Neurol. 2017 Mar;19(3):12. doi: 10.1007/s11940-017-0447-4. Epub Apr 1.
Source _ Similar articles




Grunert M, Kassubek R, Danz B, Klemenz B, Hasslacher S, Stroh S, Schneele L, Langhans J, Ströbele S, Barry SE, Zhou S, Debatin KM, Westhoff MA.
Radiation and Brain Tumors: An Overview.
Crit Rev Oncog. 2018;23(1-2):119-138. doi: 10.1615/CritRevOncog.2018025927..
Source _ Similar articles



RE-IRRADIATION



Rao AD, Rashid AS, Chen Q, Villar RC, Kobyzeva D, Nilsson K, Dieckmann K, Nechesnyuk A, Ermoian R, Alcorn S, MacDonald SM, Ladra MM, Ford EC, Winey BA, Figueiredo MLS, Chen MJ, Terezakis SA.
Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):634-641. doi: 10.1016/j.ijrobp.2017.07.026. Epub 2017 Jul 28.
Source _ Similar articles




Tsang DS, Laperriere NJ.
Re-irradiation for Paediatric Tumours.
Clin Oncol (R Coll Radiol). 2018 Oct 29. doi: 10.1016/j.clon.2018.10.003. [Epub ahead of print]
Source _ Similar articles



RADIOSURGERY



Mitrasinovic S, Zhang M, Appelboom G, Sussman E, Moore JM, Hancock SL, Adler JR, Kondziolka D, Steinberg GK, Chang SD.
Milestones in stereotactic radiosurgery for the central nervous system.
J Clin Neurosci. 2019 Jan;59:12-19. doi: 10.1016/j.jocn.2018.09.029. Epub 2018 Oct 26.
Source _ Similar articles



STEREOTACTIC BRAIN BIOPSY



Callovini GM, Telera S, Sherkat S, Sperduti I, Callovini T, Carapella CM.
How is stereotactic brain biopsy evolving? A multicentric analysis of a series of 421 cases treated in Rome over the last sixteen years.
Clin Neurol Neurosurg. 2018 Nov;174:101-107. doi: 10.1016/j.clineuro.2018.09.020. Epub 2018 Sep 13.
Source _ Similar articles



STEROIDS



Ly KI, Wen PY.
Clinical Relevance of Steroid Use in Neuro-Oncology.
Curr Neurol Neurosci Rep. 2017 Jan;17(1):5. doi: 10.1007/s11910-017-0713-6. Online 2017 Jan 30.
Source _ Similar articles



SURGERY



Bowden SG, Han SJ.
The Evolving Role of the Oncologic Neurosurgeon: Looking Beyond Extent of Resection in the Modern Era.
Front Oncol. 2018 Sep 25;8:406. doi: 10.3389/fonc.2018.00406.
Source _ Similar articles




Díez Valle R, Hadjipanayis CG, Stummer W.
Established and emerging uses of 5-ALA in the brain: an overview.
J Neurooncol. 2019 Feb;141(3):487-494. doi: 10.1007/s11060-018-03087-7. Epub 2019 Jan 3.
Source _ Similar articles




Fernandes Cabral DT, Zenonos GA, Nuñez M, Celtikci P, Snyderman C, Wang E, Gardner PA, Fernandez-Miranda JC.
Endoscopic Endonasal Transclival Approach for Resection of a Pontine Glioma: Surgical Planning, Surgical Anatomy, and Technique.
Oper Neurosurg (Hagerstown). 2018 Mar 12. doi: 10.1093/ons/opy005. [Epub ahead of print]
Source _ Similar articles




Zattra CM, Zhang DY, Broggi M, Velz J, Vasella F, Seggewiss D, Schiavolin S, Bozinov O, Krayenbühl N, Sarnthein J, Ferroli P, Regli L, Stienen MN.
Repeated craniotomies for intracranial tumors: is the risk increased? Pooled analysis of two prospective, institutional registries of complications and outcomes.
J Neurooncol. 2018 Nov 24. doi: 10.1007/s11060-018-03058-y. [Epub ahead of print]
Source _ Similar articles



THERANOSTICS




NONPROSTATIC MALIGNANCIES



Backhaus P, Noto B, Avramovic N, Grubert LS, Huss S, Bögemann M, Stegger L, Weckesser M, Schäfers M, Rahbar K.
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.
Eur J Nucl Med Mol Imaging. 2018 May;45(5):860-877. doi: 10.1007/s00259-017-3922-y. Epub 2018 Jan 15.
Source _ Similar articles




Malik D, Kumar R, Mittal BR, Singh H, Bhattacharya A, Singh SK.
68Ga-Labeled PSMA Uptake in Nonprostatic Malignancies: Has the Time Come to Remove "PS" From PSMA?
Clin Nucl Med. 2018 Apr 23. doi: 10.1097/RLU.0000000000002103. [Epub ahead of print]
Source _ Similar articles



TUMOUR TREATING FIELDS



Mirza FA, Shamim MS.
Tumour Treating Fields (TTFs) for Paediatric Brain Tumours, Brain Metastases and other Novel Applications.
J Pak Med Assoc. 2018 Nov;68(11):1729-1731.
Source _ Similar articles



Laboratory investigations



Merkel O, Taylor N, Prutsch N, Staber PB, Moriggl R, Turner SD, Kenner L.
When the guardian sleeps: Reactivation of the p53 pathway in cancer.
Mutat Res. 2017 Jul;773:1-13. doi: 10.1016/j.mrrev.2017.02.003. Epub 2017 Feb 17.
Source _ Similar articles



Clinical investigations




Newly diagnosed tumors




RIDAFOROLIMUS



Pearson AD, Federico SM, Aerts I, Hargrave DR, DuBois SG, Iannone R, Geschwindt RD, Wang R, Haluska FG, Trippett TM, Geoerger B.
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors.
Oncotarget. 2016 Oct 4. doi: 10.18632/oncotarget.12450. [Epub ahead of print]
Source _ Similar articles



SURGERY



Roth J, Constantini S.
5ALA in pediatric brain tumors is not routinely beneficial.
Childs Nerv Syst. 2017 Mar 14. doi: 10.1007/s00381-017-3371-8. [Epub ahead of print]

Source _ Similar articles



Recurrent tumors




IMETELSTAT



Salloum R, Hummel TR, Kumar SS, Dorris K, Li S, Lin T, Daryani VM, Stewart CF, Miles L, Poussaint TY, Stevenson C, Goldman S, Dhall G, Packer R, Fisher P, Pollack IF, Fouladi M, Boyett J, Drissi R.
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
J Neurooncol. 2016 Jun 27.
DOI 10.1007/s11060-016-2189-7 [Epub ahead of print]
Source _ Similar articles _ Meeting abstract



PEDIATRIC TUMORS



Becher OJ, Gilheeney SW, Khakoo Y, Lyden DC, Haque S, De Braganca KC, Kolesar JM, Huse JT, Modak S, Wexler LH, Kramer K, Spasojevic I, Dunkel IJ.
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
Pediatr Blood Cancer. 2016 Dec 30. doi: 10.1002/pbc.26409. [Epub ahead of print]
Source _ Similar articles




Gorsi HS, Malicki DM, Barsan V, Tumblin M, Yeh-Nayre L, Milburn M, Elster JD, Crawford JR.
Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience.
J Pediatr Hematol Oncol. 2018 Oct 23. doi: 10.1097/MPH.0000000000001339. [Epub ahead of print]
Source _ Similar articles



PEMBROLIZUMAB



Blumenthal DT, Yalon M, Vainer GW, Lossos A, Yust S, Tzach L, Cagnano E, Limon D, Bokstein F.
Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors.
J Neurooncol. 2016 Jul 4.
DOI 10.1007/s11060-016-2190-1 [Epub ahead of print]
Source _ Similar articles



RE-IRRADIATION



Nieder C, Andratschke NH, Grosu AL.
Re-irradiation for Recurrent Primary Brain Tumors.
Anticancer Res. 2016 Oct;36(10):4985-4995.
doi:10.21873/anticanres.11067.
Source _ Similar articles



TEMOZOLOMIDE



Egan G, Cervone KA, Philips PC, Belasco JB, Finlay JL, Gardner SL.
Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.
Bone Marrow Transplant. 2016 Apr;51(4):542-5. doi: 10.1038/bmt.2015.313. Epub 2016 Jan 4.
Source _ Similar articles